Here’s how to time your retirement to keep your healthcare costs down
Plus, more ways to lower how much you pay out of pocket for medical care in retirement. Source：MarketWatch
An oil lifeline is under threat, and markets have yet to price in the growing crisis
The Houthis escalated threats on Tuesday, risking millions of barrels of Saudi oil that had been reaching energy markets despite the U.S.Iran war.…
SpaceX’s stock looks to snap brutal losing streak as it heads for one of its best days yet
Plus, investors just found out when insiders can start dumping their shares. Source：MarketWatch
Microsoft has 3 secret weapons that could drive its stock 50% higher, analyst says
Wall Street is misjudging Microsoft’s AI strategy, according to Morgan Stanley. Source：MarketWatch
These signs suggest investors should give the software sector a second chance
Software stocks and loans have started to find their footing in July, suggesting it may be time for investors to forgive and forget. Source：MarketWatch
Why Paramount could win if it loses the Warner Bros. Discovery deal
States are trying to block Paramount’s megamerger. Shareholders should root for them. Source：MarketWatch
How to successfully deal with a micromanaging boss
Plus: Don’t Short Yourself has some exciting news. Source：MarketWatch
If timing the stock market were easy, the Iran war would have proven it. It’s done the opposite.
Active stock pickers almost always lose against the broad market. They can’t beat simple math. Source：MarketWatch
Welcome to the ‘Roaring ’20s’: Here’s how this earnings season will keep the bull market strong
Stay with the AI trade and overweight technology stocks, according to one earnings expert. Source：MarketWatch
Time to buy the dip in momentum stocks after a punishing July drawdown? Here’s what history tells us.
Investors who can stomach a little shortterm volatility are often rewarded. Source：MarketWatch
Novo Nordisk sues Eli Lilly over ads comparing GLP-1 medications
The Danish company Novo says U.S.based Lilly isn’t including the most uptodate clinical information about its drugs. Source：MarketWatch
GM’s stock bounces back as revenue grows for the first time in over a year
GM’s stock rises after a beatandraise earnings report, as revenue grows to snap a fourquarter streak of declines. Source：MarketWatch